0001921094-23-000551.txt : 20230821 0001921094-23-000551.hdr.sgml : 20230821 20230821144153 ACCESSION NUMBER: 0001921094-23-000551 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230821 DATE AS OF CHANGE: 20230821 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Denali Therapeutics Inc. CENTRAL INDEX KEY: 0001714899 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463872213 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-38311 FILM NUMBER: 231188859 BUSINESS ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 866-8548 MAIL ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Watts Ryan J. CENTRAL INDEX KEY: 0001724310 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: C/O DENALI THERAPEUTICS INC. STREET 2: 151 OYSTER POINT BLVD., 2ND FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001724310 XXXXXXXX LIVE 0001714899 Denali Therapeutics Inc. 001-38311 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 (650) 866-8548 Watts Ryan J. Officer Director Common Charles Schwab & Co., Inc.

3000 Schwab Way Westlake TX 76262

2309 52167.00 137422131 08/21/2023 NASDAQ Common 08/18/2023 Restricted Stock Lapse - See Remarks Denali Therapeutics Inc. N 2309 08/18/2023 Equity Compensation N RYAN J WATTS

161 Oyster Point Blvd South San Francisco CA 94080

Denali Therapeutics Inc. 06/16/2023 50000 1570050.00 RYAN J WATTS

161 Oyster Point Blvd South San Francisco CA 94080

Denali Therapeutics Inc. 08/10/2023 2526 63223.00 Shares sold to cover tax obligation from settlement of vested Restricted Stock Units. 08/21/2023 RYAN J WATTS